Lipogen, Israel, has increased production capacity in order to supply growing demand for their Lipogen PS (phosphatidylserine) – a patented product line for the food and beverage fortification market and the dietary supplement market in the USA.

The state-of-the-art facility in the North of Israel has completed installation of production facilities to ensure supplying Lipogen PS. This move has increased the production capacity by 100%.

“Following the FDA GRAS affirmation in 2006, we expect to increase our sales growth in the market by about 50% during 2007,” explains David Rutenberg, CEO at Lipogen. “The expansion of the production facility enables us to cut down PS cost production. Lipogen intends to penetrate the US functional foods market and achieve a significant market share. We decided to adjust our pricing structure to match the conventional rates of the functional food market. Lipogen's new prices will be implemented also in the dietary supplements market, so that both segments will benefit from this strategic move. Lipogen's mission is to help children and adults alike to improve their brain health.”

“This is the first step in implementing our strategy to maintain our leading position in the market for high-value natural PS. The US market is looking for innovative functional food solutions and is ready to use this exciting brain health ingredient in several food categories,” adds Rutenberg.
 
Lipogen, a leading PS developer since 1992, focuses on natural mental health solutions for dietary supplements and for enhancing foods and beverages.  All Lipogen products are vegetarian and kosher certified.

Visit us at Natural Products Expo West show booth no. 774

For further information, please contact:

Lipogen Ltd.
David Rutenberg
CEO
Tel:   +972 544 522 355
Fax : +972 3 548 0149
E-mail: info@lipogen.co.il
www.lipogen.co.il